Stress and pain responses in rats lacking CCK 1 receptors I. Hurwitz a,c , O. Malkesman a,c , Y. Stern a,c , M. Schroeder b,c , Y. Lavi-Avnon b,c , M. Shayit b , Y. Shavit d , G. Wolf d , R. Yirmiya d , A. Weller b,c, * a Interdisciplinary Program in the Brain Sciences, Bar Ilan University, Ramat-Gan, Israel b Department of Psychology, Bar-Ilan University, Ramat-Gan, Israel c The Gonda (Goldschmeid) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan, Israel d Department of Psychology, The Hebrew University, Jerusalem, Israel CCK is one of the most abundant peptides in the brain [9], in addition to its role as a gut-hormone in the periphery. CCK binds to two types of receptors: CCK 1 (formerly called CCK A ), localized mainly in the gastrointestinal tract, but also found on the vagus and in discrete brain areas, and CCK 2 (formerly called CCK B ), which are identical to peripheral gastrin receptors, and are widely distributed throughout the CNS [25,38–39]. Psychopharmacological research has identified many physiological and behavioral functions of CCK (e.g., [7,8]). In the current study we further examined a few of the major non-ingestive behavioral effects that might be modu- lated by CCK: natural preferences and stress- and pain- reactivity. Instead of the standard pharmacological agonist/ antagonist approach, we used a rat model in which the CCK 1 receptors are completely absent. Recently, research has demonstrated that the Otsuka Long Evans Tokushima Fatty (OLETF) rat congenitally lacks a 6 kb segment in the gene for CCK 1 receptors [36], and lacks the expression of CCK 1 receptors [11]. The 6 kb lesion is specific to the promoter-region and the first and second exons of the gene for CCK 1 receptors, yet it does not play any part in another gene, the gene for CCK 2 receptors. Therefore, it is not surprising that the expression of CCK 2 receptors was shown to be normal in OLETF rats [11]. In fact, there even may be a compensatory over-expression of CCK 2 receptors, at least at the age of 14–34 weeks [26]. peptides 27 (2006) 1483–1489 article info Article history: Received 12 June 2005 Received in revised form 10 October 2005 Accepted 10 October 2005 Published on line 11 November 2005 Keywords: USV Pain Anxiety Natural preference CCK OLETF rats abstract CCK involvement in stress- and pain-responsiveness was examined by studying the beha- vior of infant (11–12-days-old) and adult OLETF rats that do not express CCK 1 receptors. Infant odor- and texture-preferences were also assessed. We hypothesized that OLETF rats will show behavioral patterns similar to those previously observed after CCK 1 antagonist administration. Rate of separation-induced ultrasonic vocalization was significantly greater in OLETF compared to controls, in two separate studies. Infant pups of the two strains did not differ in odor- and texture-preference tests. OLETF rats showed consistently longer hot- plate paw-lift (as infants, in two separate studies) and paw-lick (as adults) latencies. Summary: OLETF pups vocalized in isolation more than controls and showed relative hypoalgesic responses, evident also in adulthood, in concordance with the pharmacological literature. # 2005 Elsevier Inc. All rights reserved. * Corresponding author at: Developmental Psychobiology Laboratory, Department of Psychology, Bar-Ilan University, Geha Road, Ramat- Gan IL52900, Israel. Tel.: +972 3 5318548; fax: +972 3 535 0267. E-mail address: [email protected] (A. Weller). available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/peptides 0196-9781/$ – see front matter # 2005 Elsevier Inc. All rights reserved. doi:10.1016/j.peptides.2005.10.009
7
Embed
Stress and pain responses in rats lacking CCK1 receptors
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Stress and pain responses in rats lacking CCK1 receptors
I. Hurwitz a,c, O. Malkesman a,c, Y. Stern a,c, M. Schroeder b,c, Y. Lavi-Avnon b,c,M. Shayit b, Y. Shavit d, G. Wolf d, R. Yirmiya d, A. Weller b,c,*a Interdisciplinary Program in the Brain Sciences, Bar Ilan University, Ramat-Gan, IsraelbDepartment of Psychology, Bar-Ilan University, Ramat-Gan, IsraelcThe Gonda (Goldschmeid) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan, IsraeldDepartment of Psychology, The Hebrew University, Jerusalem, Israel
p e p t i d e s 2 7 ( 2 0 0 6 ) 1 4 8 3 – 1 4 8 9
a r t i c l e i n f o
Article history:
Received 12 June 2005
Received in revised form
10 October 2005
Accepted 10 October 2005
Published on line 11 November 2005
Keywords:
USV
Pain
Anxiety
Natural preference
CCK
OLETF rats
a b s t r a c t
CCK involvement in stress- and pain-responsiveness was examined by studying the beha-
vior of infant (11–12-days-old) and adult OLETF rats that do not express CCK1 receptors.
Infant odor- and texture-preferences were also assessed. We hypothesized that OLETF rats
will show behavioral patterns similar to those previously observed after CCK1 antagonist
administration. Rate of separation-induced ultrasonic vocalization was significantly greater
in OLETF compared to controls, in two separate studies. Infant pups of the two strains did
not differ in odor- and texture-preference tests. OLETF rats showed consistently longer hot-
plate paw-lift (as infants, in two separate studies) and paw-lick (as adults) latencies.
Summary: OLETF pups vocalized in isolation more than controls and showed relative
hypoalgesic responses, evident also in adulthood, in concordance with the pharmacological
similar to those of LETO controls. Overall, this pattern of
results could be the consequence of one or more of the
following possibilities: the lack of a moderating CCK1
mediated effect, a compensatory super-sensitivity of CCK2
receptors, or compensatory changes in other, non-CCK
systems, that modulate stress, pain, and preference beha-
viors.
Regarding USV, the pattern of results confirms, in general,
the findings obtained with the pharmacological approach.
While exogenously administered CCK-8 reduced USV [42],
OLETF pups emitted significantly more USV than controls
(Fig. 1), just as pups treated with the selective antagonist of
CCK1 receptors, devazepide, produced more USV than controls
in two previous studies [4,43]. There are, though, a few
differences in the details. Devazepide has not been shown to
increase USV alone, but rather to block USV-decrease induced
by oral ingestion of milk or corn-oil. In contrast, OLETF rats
were shown here to produce more USV than controls, while
isolated in an empty cup, or in a plastic box containing a paper
towel, damp with water. However, when the towel contained
sweetened milk, the OLETF–LETO difference was not signifi-
cant. This finding is most interesting, because it may suggest
that in the absence of CCK1 receptors, OLETF pups may be
super-sensitized to other neurochemical systems that reduce
USV in response to milk (e.g., opioids; [3]). The possible
development of such adaptive, compensatory mechanisms
should be tested in future studies.
Recently, we have reported, in a study of siblings of the
current subjects, that OLETF pups separated from the dam and
then returned to a foster (OLETF or LETO) dam individually for
10 min, emitted significantly more USV than LETO pups who
underwent an identical procedure [19]. The current findings
extend those results, by showing higher USV levels in OLETF
pups, not only while interacting with a foster dam, but even
when alone, during an isolation test. Taken together, the two
studies strengthen the conclusion that rat pups lacking
functional CCK1 receptors vocalize more than controls.
These findings may be relevant to a study that found low
CCK levels in colicky (excessively crying) human infants. The
authors speculated that colicky infants have impaired CCK
secretion, which contributes to their gallbladder hypocon-
tractility (reported earlier) and excessive crying [15].
Regarding pain, the hypoalgesia on the hot-plate paw-
removal response found in OLETF rats (Fig. 3) was robust,
appearing in two replications in infant rats and in adults. This
finding corroborates a previous report of hypoalgesia in six
adult OLETF rats [22]. The two studies that are not in
accordance with this result reported no differences between
adult OLETF and LETO rats, assessed by a different pain assay
(tail-flick, 21) and no effect of IP administration of CCK-
octapeptide on PLL in infant Sprague-Dawley rats [42].
Although our current finding of hypoalgesia in OLETF rats
may be due to an alteration in the number or sensitivity of
CCK2 receptors, it is more plausible to suggest that CCK1
receptors normally play a hyperalgesic modulatory role, at
least in the context of the mildly stressful hot-plate test, and
p e p t i d e s 2 7 ( 2 0 0 6 ) 1 4 8 3 – 1 4 8 91488
therefore the absence of these receptors results in a relative
hypoalgesia in the OLETF rat.
Regarding natural preferences, as expected, control LETO
pups demonstrated relative texture- and maternal-odor pre-
ferences, thus replicating our results in Sprague-Dawley rats.
However, the preferences of OLETF rats did not differ, in marked
contrast to our previous results with CCK receptor antagonists.
Note that these ‘‘negative’’ results appear to be highly reliable.
First, they were conceptually replicated in two separate studies
of siblings from the same litters. Second, the experimenters
were blind to the pups’ strain. Third, while the groups did not
differ in their preference levels, significant OLETF–LETO
differences were indeed observed when comparing pups from
the same litters on other behavioral measures (USV and PLL,
Experiment 1, above). Fourth, from our experience [32,34] the
preference levels demonstrated in the current study were
moderate, allowing for further increases in preference levels.
This argues against the possibility of a ‘‘ceiling effect’’. Taken
together, the results show that OLETF pups preferred the test
stimuli to a similar degree as LETO controls. They did not show a
greater preference (as was the case in Sprague-Dawley rats
treated with CCK-receptor antagonists). It is possible that the
neurochemical systems relevant for these preferences have
undergone compensatory processes in OLETF rats during the
prenatal and postnatal periods preceding our experiment. We
note that the previous findings in which selective antagonists of
both 1- and 2-type receptors produced similar effects did not
allow for a clear prediction for the pattern of preference to be
expected in OLETF pups.
Experiments 1 and 3 were performed in infants, before the
age in which OLETF rats become diabetic and obese [17,24]. To
verify this issue, we examined glucose levels from a different
study, in progress. No significant OLETF–LETO differences
were found on postnatal day 7 (overall mean glucose
levels = 101.9 mg/dl, N = 21) and on postnatal day 15
(123.8 mg/dl, N = 17). A potential limitation of this study is
the lack of body temperature measurement. USV are affected
by ambient temperature [18], which was measured and was
stable during Experiment 1. Nevertheless, it is conceivable that
a portion of the USV differences reported above, obtained at
standard room temperature, could be explained by reactivity
to differential ambient-body temperature differentials, if
OLETF and LETO pups differed in body temperature. To
examine this we measured, in a follow-up study, axillary
temperatures of 25 OLETF and 20 LETO pups from 11 litters
at the ages of PND 10–12. After 2 h group housing in an
incubator, temperature was measured. They were then placed
individually in a clean cage with bedding at room temperature
(24–25 8C) for 10–15 min, and then temperature was measured
again. Two-way ANOVA showed that there was no significant
temperature difference between the strains (mean LETO =
35.6 8C, OLETF = 36.2 8C). Temperature decreased overall sig-
nificantly over time (average from 36.4 to 35.4 8C), with no
interaction between strain and time. Thus, the concern
regarding body temperature differences is not supported.
One final limitation of this study should be mentioned. The
adult OLETF rat has been characterized as lacking CCK1
receptors. OLETF rats did not differ from controls (when
hyperphagia and increased body weight were controlled by
pair-feeding) in hypothalamic POMC and NPY in the arcuate
nucleus and in the leptin receptor (long form, Ob–Rb).
However, they are characterized by overexpression of NPY
in the dorsal medial hypothalamus [2]. Nevertheless, this
model derives from selective breeding, not single-gene-
mutation technology. Therefore, it is still possible that some
other, as yet not identified genes may also be malfunctioning
in the OLETF rat, a gene that may affect stress and pain
reactivity by a non-CCK pathway, ultimately accounting for
our current results by an alternative mechanism.
Acknowledgements
The rats were a generous gift of Dr. Kawano of Tokushima
Research Institute and Otsuka Pharmaceutical, Tokushima,
Japan. The authors thank Ofra Schwartz for animal care and
careful maintenance of ‘‘blind’’ coding of the litters’ geno-
types. The authors thank Adi David, Itay Peleg, Danielle
Schwartz and Daniel Markovitz for help in data collection. OM
and YLA were supported by the President’s doctoral fellow-
ship, Bar-Ilan University. OM was supported beforehand by a
fellowship from Bar-Ilan University’s Interdisciplinary Studies
Committee. This work was supported by a grant from the
Israel Science Foundation to AW.
r e f e r e n c e s
[1] Barbaz BS, Hall NR, Liebman JM. Antagonism of morphineanalgesia by CCK-8-S does not extend to all assays nor allopiate analgesics. Peptides 1989;9:1295–300.
[2] Bi S, Ladenheim EE, Schwartz GJ, Moran TH. A role for NPYoverexpression in the dorsomedial hypothalamus inhyperphagia and obesity of OLETF rats. Am J Physiol2001;281:R254–60.
[3] Blass EM, Fitzgerald E. Milk-induced analgesia andcomforting in 10-days-old rats: opioid mediation.Pharmacol Biochem Behav 1988;29:9–13.
[5] Blumberg S, Haba D, Schroeder M, Smith GP, Weller A.Independent ingestion and microstructure of feedingpatterns in infant rats lacking CCK1 receptors. Am J Physiol2005, in press.
[6] Brunelli SAB, Hofer MA. Selective breeding for an infantilephenotype (isolation calling): a window on developmentalforces. In: Blass EM, editor. Handbook of behavioralneurobiology, vol. 13. New York: Plenum Press; 2001. p. 433–
[8] Dauge V, Bohme GA, Crawley JN, Durieux C, Stutzmann JM,Feger J, et al. Investigation of behavioral andelectrophysiological responses induced by selectivestimulation of CCK-B receptor by using a new highly potentCCK analog, BC264. Synapse 1990;6:73–80.
[9] Dockray GJ. Immunochemical evidence ofchoolecystokinin-like peptides in brain. Nature1976;264:568–70.
[10] Dourish CT, Hawley D, Iversen SD. Enhancement ofmorphine analgesia and prevention of morphine tolerancein the rat by the cholecystokinin antagonist L-364,718. Eur JPharmacol 1988;147:469–72.
p e p t i d e s 2 7 ( 2 0 0 6 ) 1 4 8 3 – 1 4 8 9 1489
[11] Funakoshi A, Miyassaka K, Shinozaki H, Masuda M,Kawanami T, Takata Y, et al. An animal model ofcongenital defect of gene expression of cholecystokinin(CCK)-A receptor. Biochem Biophys Res Commun1995;210:787–96.
[12] Harhammer R, Schafer U, Henklein P, Ott T, Repke H.CCK-8-related C-terminal tetrapeptides: affinities forcentral CCKB and peripheral CCKA receptors. Eur JPharmacol 1991;209:263–6.
[13] Hofer MA. Multiple regulators of ultrasonic vocalization inthe infant rat. Psychoneuroendocrinology 1996;21:203–17.
[14] Hokfelt T, Holmberg K, Shi TJ, Broberger C. CCK-ergicmechanisms in sensory systems. Scand J Clin Lab InvestSuppl 2001;234:69–74.
[16] Insel TR, Winslow JT. Rat pup ultrasonic vocalizations: anethologically relevant behavior responsive to anxiolytics.In: Olivier B, Mos J, Slangen JL, editors. Animal modelsin psychopharmacology. Basel: Birkhauser-Verlag; 1991. p.15–36.
[17] Kawano KT, Hirashima S, Mori S, Saitoh Y, Kurosumi M,Natori T. Spontaneous long-term hyperglycemic rat withdiabetic complications: Otsuka Long Evans TokushimaFatty (OLETF) strain. Diabetes 1992;41:1422–8.
[18] Kraebel KS, Brasser SM, Campbell JO, Spear LP, Spear NE.Developmental differences in temporal patterns andpotentiation of isolation-induced ultrasonic vocalizations:Influence of temperature variables. Dev Psychobiol2002;40:147–59.
[19] Lavi-Avnon Y, Malkesman O, Hurwitz I, Weller A. Mother–infant interactions in rats lacking CCKA receptors. BehavNeurosci 2004;118:282–9.
[20] Lavigne GJ, Millington WR, Mueller GP. The CCK-A andCCK-B receptor antagonists, devazepide and L-365,260,enhance morphine antinociception only in non-acclimatedrats exposed to a novel environment. Neuropeptides1992;21:119–29.
[21] Lee GS, Han JB, Shin MK, Hong MC, Kim SW, Min BI, et al.Enhancement of electroacupuncture-induced analgesiceffect in cholecystokinin-A receptor deficient rats. BrainRes Bull 2003;62:161–4.
[22] Li X-L, Aou S, Hori T, Oomura Y. Spatial memory deficit andemotional abnormality in OLETF rats. Physiol Behav2002;75:15–23.
[23] Miyasaka K, Kobayashi S, Ohta M, Kanai S, Yoshida Y,Nagata A, et al. Anxiety-related behaviors incholecystokinin-A, B, and AB receptor gene knockout micein the plus-maze. Neurosci Lett 2002;335:115–8.
[24] Moran TH, Katz LF, Plata-Salaman CR, Schwartz GJ.Disordered food intake and obesity in rats lackingcholecystokinin A receptors. Am J Physiol 1998;274:R618–25.
[25] Moran TH, Robinson PH, Goldrich MS, McHugh PR. Twobrain cholecystokinin receptors: implications forbehavioral actions. Brain Res 1986;362:175–9.
[26] Nakamura H, Kihara Y, Tashiro M, Kanagawa K, ShiroharaH, Yamamoto M, et al. Defects of cholecystokinin (CCK)-Areceptor gene expression and CCK-A receptor-mediatedbiological functions in Otsuka Long Evans Tokushima Fatty(OLETF) rats. J Gastroenterol 1998;33:702–9.
[27] Noble F, Roques BP. The role of CCK2 receptors in thehomeostasis of the opioid system. Drugs Today (Barc)2003;39:897–908.
[28] Nomoto S, Miyake M, Ohta M, Funakoshi A, Miyasaka K.Impaired learning and memory in OLETF rats withoutcholecystokinin (CCK)-A receptor. Physiol Behav1999;66:869–72.
[29] Olivier B, Molewijk HE, van der Heyden JAM, van OorschotR, Mos J, Miczek KA. Ultrasonic vocalizations in rat pups:Effects of serotonergic ligands. Neurosci Biobehav Rev1998;23:215–27.
[30] Rastegar H, Homayoun H, Afifi M, Rezayat M, Dehpour AR.Modulation of cholestasis-induced antinociception by CCKreceptor agonists and antagonists. EurNeuropsychopharmacol 2002;12:111–8.
[31] Rex A, Barth T, Voigt J-P, Domeney AM, Fink H. Effects ofcholecystokinin tetrapeptide and sulfated cholecystokininoctapeptide in rat models of anxiety. Neurosci Lett1994;172:139–42.
[32] Rakover-Atar S, Weller A. The influence of naturalpreference for tactile stimuli on appetitive learning in ratpups. Dev Psychobiol 1997;30:29–39.
[33] Sei M, Sei H, Shima K. Spontaneous activity, sleep, andbody temperature in rats lacking the CCK-A receptor.Physiol Behav 1999;68:25–9.
[34] Shayit M, Weller A. Cholecystokinin receptor antagonistsincrease the rat pup’s preference towards maternal-odorand rug texture. Dev Psychobiol 2001;38:164–73.
[35] Suh HW, Kim YH, Choi YS, Song DK. Involvement ofdifferent subtypes of cholecystokinin receptors in opioidantinociception in the mouse. Peptides 1995;16:1229–34.
[36] Takiguchi S, Takata Y, Funakoshi A, Miyasaka K, Kataoka K,Fujimura Y, et al. Disrupted cholecystokinin type-Areceptor (CCKAR) gene in OLETF rats. Gene 1997;197:169–75.
[37] Tortorici V, Nogueira L, Salas R, Vanegas H. Involvement oflocal cholecystokinin in the tolerance induced by morphinemicroinjections into the periaqueductal gray of rats. Pain2003;102:9–16.
[38] Wank SA. G protein-coupled receptors in gastrointestinalphysiology I. CCK receptors: an exemplary family. Am JPhysiol 1998;274:G607–13.
[39] Wank SA, Pisegna JR, De Weerth A. Brain andgastrointestinal cholecystokinin receptor family: structureand functional expression. Proc Natl Acad Sci USA1992;89:3125–9.
[41] Weller A. The ontogeny of motivation: Hedonic preferencesand their biological basis in developing rats. In: Blass EM,editor. Handbook of Behavioral Neurobiology, vol. 13. NewYork: Plenum Press; 2001. p. 483–516.
[42] Weller A, Blass EM. Behavioral evidence forcholecystokinin–opiate interactions in neonatal rats. Am JPhysiol 1988;255:R901–7.
[43] Weller A, Gispan IH. A cholecystokinin receptor antagonistblocks milk-induced but not maternal-contact-induceddecrease in ultrasonic vocalization in rat pups. DevPsychobiol 2000;37:35–43.
[44] Weller A, Tsitolovskya L, Gispan IH, Rabinowitz S.Examining the role of cholecystokinin in appetitivelearning in the infant rat. Peptides 2001;22:1317–23.
[45] Wolf G, Yirmiya R, Goshen I, Iverfeldt K, Holmlund L,Takeda K, et al. Impairment of interleukin-1 (IL-1) signalingreduces basal pain sensitivity in mice: genetic,pharmacological and developmental aspects. Pain2003;104:471–80.
[46] Xie JY, Herman DS, Stiller CO, Gardell LR, Ossipov MH, Lai J,et al. Cholecystokinin in the rostral ventromedial medullamediates opioid-induced hyperalgesia and antinociceptivetolerance. J Neurosci 2005;25:409–16.
[47] Yamamoto Y, Akiyoshi J, Kiyota A, Katsuragi S, Tsutsumi T,Isogawa K, et al. Increased anxiety behavior in OLETF ratswithout cholecystokinin-A receptor. Brain Res Bull2000;53:789–92.